title: The relationship between inhalational anesthetic requirements and the severity of liver disease in liver transplant recipients according to three phases of liver transplantation.
abstract: OBJECTIVE
  Orthotopic liver transplantation (OLT) patients are known to show decreased intraoperative anesthetic requirements compared with patients undergoing other liver surgeries. The aim of this study was to determine the relationship between inhalational anesthetic requirements and the severity of liver disease among OLT patients.
  
  
  METHODS
  Fifty patients undergoing first living donor OLT were divided into 2 groups: model for end-stage liver disease (MELD) score<20 (low-MELD group; n=25) versus, MELD score>or=20 (high-MELD group; n=25). Anesthesia was maintained with desflurane and inspired concentration was titrated to maintain the bispectral index between 40 and 50. Neither intraoperative opioid nor epidural or intrathecal analgesia was used. End-tidal desflurane concentration (ETdes) was measured every 5 minutes and averaged in 30-minute intervals. These values were divided into 3 phases: preanhepatic (P 0.5 hour, P 1 hour, and P 1.5 hours), anhepatic (A 0.5 hour, A 1 hour, A 1.5 hours, and A 2 hours), and postreperfusion (R 0.5 hour, R 1 hour, R 1.5 hours, R 2 hours, R 2.5 hours, and R 3 hours). Results were compared between the 2 groups.
  
  
  RESULTS
  The demographic and intraoperative data were similar between the 2 groups. ETdes to maintain comparable anesthetic depth was significantly lower during the preanhepatic and anhepatic phases in the high-MELD than the low-MELD group, but there was no significant difference during the postreperfusion period.
  
  
  CONCLUSIONS
  OLT patients with high MELD scores showed less inhalational anesthetic requirements during the preanhepatic and the anhepatic periods than those with low MELD scores.
authors.affiliation: Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: J G
authors.initials: JG
authors.lastname: Kang
authors.forename: J S
authors.initials: JS
authors.lastname: Ko
authors.forename: G S
authors.initials: GS
authors.lastname: Kim
authors.forename: M S
authors.initials: MS
authors.lastname: Gwak
authors.forename: Y R
authors.initials: YR
authors.lastname: Kim
authors.forename: S-K
authors.initials: SK
authors.lastname: Lee
mesh_terms: D000328:Adult; D018685:Anesthetics, Inhalation / Q000627:therapeutic use*; D000077335:Desflurane; D005260:Female; D006526:Hepatitis C / Q000150:complications / Q000601:surgery; D006801:Humans; D007530:Isoflurane / Q000031:analogs & derivatives / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000150:complications / Q000601:surgery; D008107:Liver Diseases / Q000473:pathology / Q000601:surgery*; D017114:Liver Failure, Acute / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index
chemical_list: D018685:Anesthetics, Inhalation; D000077335:Desflurane; D007530:Isoflurane